Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer

In this comparative effectiveness study of UK BRCA carriers, the estimand differed from other ongoing clinical effectiveness studies of RRES and DO. Advantages include direct use of expected risk at baseline (unknown at design stage), easier interpretation across cohorts than absolute risk differences, and providing a feasible recruitment target for PROTECTOR to evaluate clinical effectiveness.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-09-16
DOI
https://doi.org/10.1001/jamanetworkopen.2025.32195
Citations
2
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
3.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer

Sonali Kaushik, Rema Iyer, Emma J. Crosbie, Laura Casey et al.
2 citations
JAMA Network Open
Ovarian cancer diagnosis and treatment
3.40
article

Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer

Sonali Kaushik, Rema Iyer, Emma J. Crosbie, Laura Casey, Mahalakshmi Gurumurthy, Helena Misiura, W. Glenn McCluggage, Caitlin T. Fierheller, Timothy J. Duncan, Maria Marks, Partha Pratim Sengupta, Asma Faruqi, Helen Hanson, Halimah Alazzani, Monika Oktaba, Katharine Edey, Jenifer Sassarini, Andrew Phillips, G.T. McArdle, Jane Borley, Annika Idahl, Peter David Sasieni, Ranjit Manchanda, Kalpana Ragupathy, Adam N. Rosenthal, Neil Ryan, Monica Tryczynska, Gemma Reig, Jacqueline Sia, Richard Hutson, Hyun Joo Doh, Gareth Bryson, Raji Ganesan, Lucy Side, John D. Dalton, Janos Balega, Ertan Sarıdoğan, Sudha Sundar, T. R. E. Pilkington, Kathryn Baxter, Sadaf Ghaem‐Maghami, Manon van Seters, C. Gnanachandran, S. Kodiathodi, Richard Peevor, Scott Fegan, Gareth Rowlands, Ashwin Kalra, Samuel Oxley, Beena Abdul, Supratik Chattopadhyay, Mayuri Prasad, Natalia Povolotskaya, Rosa Legood, Nazish Zulfiqar, Claire Newton, Michail Sideris, Karin Williamson, Jacqueline McDermott, Thet Khaing, Irene Ray, Adam R. Brentnall, Rupali Arora, Usha Menon, Michelle L. MacKintosh, Kelly Kohut, Naveena Singh, Katie M.G. Snape, Anil Tailor, Mark Willett, D. Gareth Evans, Omer Devaja, Victoria Barker, R O’Donnell, Atiyah Kamran, Wei Xia, Aarti Sharma, Munaza Ahmed, Mohamed Abdelaziz, Claire Park, Priyanka Deshmukh, Giorgia Trevisan, Siân Taylor, Holly Fraser, Bianca de Souza, S. A. Rao, Nicholas Matthews, Iain Cameron, Emily F. Lane, Amal Singh, Ian Harley, Tony Chalhoub, Angela F. Brady, Gautam Mehra, Hisham Hamed, Subhasheenee Ganesan, Helen Bolton, Lea Mansour, Nataliya Piletska, Roula Elboraei, Victor Ohwo
article en
2 citations

Abstract

In this comparative effectiveness study of UK BRCA carriers, the estimand differed from other ongoing clinical effectiveness studies of RRES and DO. Advantages include direct use of expected risk at baseline (unknown at design stage), easier interpretation across cohorts than absolute risk differences, and providing a feasible recruitment target for PROTECTOR to evaluate clinical effectiveness.

JAMA Network OpenVol. 8(9)
Belfast Health and Social Care Trust (GB), University College London Hospitals NHS Foundation Trust (GB), Queen Mary University of London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Barts Health NHS Trust (GB), University of Exeter (GB), Royal Devon & Exeter NHS Foundation Trust (GB), Manchester Academic Health Science Centre (GB), Medical Protective (US), London School of Hygiene & Tropical Medicine (GB), MRC Clinical Trials Unit at UCL (GB), Birmingham Women’s and Children’s NHS Foundation Trust (GB), University College London (GB), Umeå University (SE)
Cancer Research UK, National Institute for Health and Care Research, Ovarian Cancer Action, Wellbeing of Women, Rosetrees Trust, Manchester Biomedical Research Centre, Medical Research Council
Openalex Percentile: Top 7%
Ovarian cancer diagnosis and treatment
3.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.